Skip to main content
. 2022 Dec 30;12(7):7844–7858. doi: 10.1002/cam4.5551

FIGURE 2.

FIGURE 2

The process of CAR‐T‐cell therapy. Peripheral blood samples are taken from the patient. T cells are isolated and genetically engineered to present chimeric antigen receptors (CARs) and recognize a specific tumor associated antigen (TAAs). The obtained CAR‐T cells are expanded, and infused to the patient.